MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,768K
Net Income
-$17,183K
Net Profit Margin
-620.77%
EPS
-$0.27
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
License and collaboration revenues
2,768
16*
16
-
Research and development expense
16,273
10,910*
11,110
-
General and administrative expense
4,099
591*
6,583
-
Total operating expenses
20,372
11,501*
17,693
-
Loss from operations
-17,604
-11,485*
-17,677
-
Interest income
313
633*
545
-
Other income (expense)
67
544*
-7
-
Total other income, net
380
1,177*
538
-
Net loss before income tax
-17,224
-10,308*
-17,139
-12,844
Income tax expense
60
23*
61
55
Net loss
-17,284
-10,331*
-17,200
-12,899
Foreign currency translation adjustments
102
-7*
87
236
Unrealized losses on available-for-sale investments
-1
-9*
11
-6
Comprehensive loss
-17,183
-10,348
-17,102
-12,669
Basic EPS
-0.27
-0.186
-0.31
-0.23
Diluted EPS
-0.27
-0.186
-0.31
-0.23
Basic Average Shares
62,884,000
55,766,000
55,716,000
55,498,000
Diluted Average Shares
62,884,000
55,766,000
55,716,000
55,498,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$17,183K
(-35.63%↓ Y/Y)
Foreign currency
translation adjustments
$102K
(-56.78%↓ Y/Y)
Net loss
-$17,284K
(-33.99%↓ Y/Y)
Unrealized losses on
available-for-sale investments
-$1K
(83.33%↑ Y/Y)
Interest income
$313K
Other income
(expense)
$67K
Net loss before
income tax
-$17,224K
(-34.10%↓ Y/Y)
Income tax expense
$60K
(9.09%↑ Y/Y)
Total other income,
net
$380K
Loss from operations
-$17,604K
License and
collaboration revenues
$2,768K
Total operating
expenses
$20,372K
Research and development
expense
$16,273K
General and
administrative expense
$4,099K
Buy us a coffee
Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Ltd (CNTB)